Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2025)

Historic Retained Earnings for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $138.4 million.

  • Harmony Biosciences Holdings' Retained Earnings rose 39289.02% to $138.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.4 million, marking a year-over-year increase of 39289.02%. This contributed to the annual value of $2.2 million for FY2024, which is 10154.67% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Retained Earnings is $138.4 million, which was up 39289.02% from $87.6 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Retained Earnings' 5-year high stood at $138.4 million during Q3 2025, with a 5-year trough of -$480.8 million in Q1 2021.
  • Its 5-year average for Retained Earnings is -$212.9 million, with a median of -$208.3 million in 2023.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Retained Earnings skyrocketed by 239.25% in 2021, and later skyrocketed by 39289.02% in 2025.
  • Harmony Biosciences Holdings' Retained Earnings (Quarter) stood at -$453.6 million in 2021, then surged by 40.01% to -$272.1 million in 2022, then surged by 47.35% to -$143.3 million in 2023, then soared by 101.55% to $2.2 million in 2024, then surged by 6146.25% to $138.4 million in 2025.
  • Its last three reported values are $138.4 million in Q3 2025, $87.6 million for Q2 2025, and $47.8 million during Q1 2025.